“LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE”, Mediterr J Hematol Infect Dis, vol. 3, no. 1, p. e2011021, May 2011, doi: 10.4084/mjhid.2011.021.